preferred embodiments of the invention provide recombinant dna - molecule complexes including two dna - molecules . the chimeric heavy chain can either comprise a dna - sequence encoding the v h - region of hybridoma cell line d9d10 , the genomic human constant γ1 - sequence of vector pbgs18 - huigg1 ( for sequence human igg1 see : takahashi et al . cell 29 : 671 - 679 ( 1982 )) downstream thereof and an intron between them , or the v h - region of hybridoma cell line d9d10 and the genomic human constant domains of vector pbgs18 - huigg1 . chimeric light chains can comprise a dna - sequence encoding the v k - region of hybridoma cell line d9d10 , the genomic human c k - region of vector psvhyghuck ( orlandi et al ., proc . natl . acad . sci . usa 81 : 7161 - 7165 ( 1984 )) downstream thereof and an intron between them or the v k - region of hybridoma cell line d9d10 and the c k - region of the vector puchuck - nar ( dubois , phd - thesis ( 1989 )). both chimeric light chains can be combined with both chimeric heavy chains , thereby providing four possible combinations . in another preferred embodiment of the invention , the recombinant dna - molecule complex comprises one recombinant dna - molecule encoding a fv - fragment of an anti - human - interferon - γ antibody , comprising a dicistronic dna - sequence encoding the v h - region of hybridoma cell line d9d10 and the v k - region of hybridoma cell line d9d10 downstream thereof , a suitable promoter region upstream of the dicistronic dna - sequence and a suitable terminator region downstream of the dicistronic dna - sequence . both v - regions might optionally be connected by means of a linker peptide . upstream of both cistrons leader - peptide sequences are preferably comprised . the leader - peptide sequence can , for example , be the pe1b - leader peptide sequence . for detecting the fv - fragrnent in an elisa , a dna - sequence encoding the tag1 - polypeptide is comprised downstream of the v k - region . between the v h - region and v k - region a dna - sequence encoding a linker peptide can optionally be comprised . the sequence of the linker peptide is represented by formula ic . a method for producing an anti - human - interferon - γ chimeric antibody or antibody fragment comprises the steps of : b ) transfecting a suitable host cell with the recombinant dna - molecule complex to obtain a recombinant host cell capable of expressing said anti - human - interferon - γ chimeric antibody or antibody fragment ; and c ) culturing said recombinant host cell so as to allow for the expression of said anti - human - interferon - γ chimeric antibody or antibody fragment . the present invention will be further illustrated by the following examples . isolation and amplification of the v h - and v k fragment of anti - huifn - γ the nucleotide sequence of both the 5 ′- and the 3 ′- ends of the v - regions of immnunoglobulins is strongly conserved . because of that , it is possible to define oligonucleotides capable of amplifying the v h - and v k - regions of practically every mouse antibody ( see orlandi et al . ( 1989 ). proc . natl . acad . sci . usa 86 : 3833 - 3837 ). the primers for the amplification of the v h - regions are : vh1back : ( seq id no : 1 ) 5 ′ aggtsmar ctgcag sagtcwgg 3 ′ psti vh1for : ( seq id no : 2 ) 5 ′ tgaggagac ggtgacc gtggtcccttggcccc 3 ′. bsteii wherein : s = c or g m = a or c r = a or g w = a or t vk2back : ( seq id no : 3 ) 5 ′ gacatc gagctc acccagtctcca 3 ′ saci vk2for : ( seq id no : 4 ) 5 ′ gtttgat ctcgag cttggtgcc 3 ′ xhoi by the introduction of restriction sites in the amplified dna - fragment , the cloning of the fragments is considerably simplified . for the amplification of 1 μg mrna of d9d10 , the first cdna strand was synthesized in a way well known in the art . for this , 100 pmol random hexanucleotide was used as a primer because after pcr a more specific dna - fragment was obtained therewith than when a pcr - oligonucleotide was used for the first strand synthesis . the amplification of the desired fragment was performed on the reaction product of the first strand cdna synthesis with the two specific primers in a 50 μl reaction mixture comprising 10 mm tris - hcl ph 8 . 3 , 50 mm kcl , 1 . 5 mm mgcl 2 , 0 . 1 mg / ml gelatine , 0 . 25 mm dntp , 25 pmol per oligonucleotide primer and 2 . 5 u taq - polymerase . the reaction mixture was covered with 2 drops paraffin oil and subjected to 30 to 35 cycles of 30 sec . 95 ° c . ( denaturation ), 35 sec . 61 ° c . ( annealing ) and 25 sec . 72 ° c . ( filling - in reaction ) with a last filling - in of 5 min . at 72 ° c . for performing the pcr , a programmable thermic block was used ( pch - 2 ; techne , cambridge , gb ). electrophoresis of 5 μl of the reaction mixture on a 2 % agarose gel showed the degree of purity and the yield of the amplified dna - fragment . the other 45 μl were subjected to chloroform extraction ( 400 μl ) after which the dna was precipitated with naa - c / ethanol . on this the desired reactions with the restriction enzymes were subsequently performed . the expression vector psvgptmovhnp comprises an immunoglobulin enhanced ( e ), - promoter ( pr ) and - leader peptide ( l ), and a v h - region from an antibody with a specificity for 4 - hydroxyl - 3 - nitrophenacetyl ( np ). the unique restriction sites bamhi and hindiii allow the insertion of new sets of ( pr - l - v ). the vector also comprises an ampicillin resistance gene for selection in bacteria and a guanine - phosphoribosyl - transferase gene of e . coli ( ecogpt ) for selection in eukaryotic cells . the vector psvhyghuck is a similar expression vector wherein the human c k sequence is already inserted behind the ( e - vl ) region . the vector comprises the selection marker hygromycin ( hyg ) through which eukaryotic cells after transfection become resistant against this antibiotic . ampicillin allows selection in bacteria . the vector was a gift from dr . jones ( medical research council , cambridge , gb ). the promoter ( pr )-, leader peptide ( l )- and v h - regions of the vector psvgptmovhnp are replaced by a dna - sequence comprising the desired promoter and signal peptide sequences , the murine v h - region of antibody d9d10 and the desired human constant domains for obtaining an expression vector encoding a chimeric heavy chain containing an intron between v and c . the v l - region of the expression vector psvhyghuck was replaced with a dna - construct comprising the desired promoter and signal peptide sequences and the murine v k - region of antibody d9d10 to obtain an expression vector encoding a chimeric light chain with an intron between the v k and c k regions . for the construction of expression vectors encoding a chimeric heavy chain without an intron between v and c , the pr - l - v h - region of the expression vector psvgpt - movhnp was replaced by a dna - sequence comprising the desired promoter and leader peptide sequences , and a region without an intron comprising the murine v h - domain together with a small part of the c h ′ - domain of the mouse directly linked to the first human c h - domain , thus obtaining an expression vector encoding a chimeric heavy chain without an intron between v and c . for the chimeric light chain without an intron between v and c , the v l - region and part of the human c k - region of the expression vector psvhyghuck were replaced by a dna - sequence comprising the desired promoter and leader peptide sequences and a dna - stretch comprising the murine v k - domain , part of the c k ′ - domain of the mouse and part of the desired human c k - domain . fig1 and 2 show schematically the construction of plasmids encoding the chimeric l and h - chain genes with and without an intron between the v - and c - regions . the v h - region of d9d10 obtained with pcr was inserted as a psti - bsteii fragment into vector m13vhpcr1 . this vector was described by orlandi et al ., proc . natl . acad . sci . usa 81 : 7161 - 7165 ( 1984 ). thus , the phage m13vhifng was obtained . the ( pr - l - v h )- region was subsequently inserted as a bamhi - hindiii - fragment into the expression vector psvgptmovhnp through which it was positioned behind the ig - enhancer ( e ) of the expression vector . thus , clone psvgptvhifng was obtained . the genomic human γ - sequence of the vector pbgs18huigg1 ( a gift from dr . honjo , department of medical chemistry , kioto , japan ) was inserted behind the pr - l - v h - region in the unique bamhi - site of psvgptvhifng to obtain the vector psvgptgfh1 encoding a chimeric heavy chain with an intron . the construction of this chimeric heavy chain is schematically demonstrated in fig3 . the v k - fragment of d9d10 was cloned as a pvuii - bglii - fragment into the pvuii - bcli - restriction site of vector m13vkpcr1 . since bcli only splices when the adenin residues in this site ( tgatca ) are not methylated , damnegative e . coli cells had to be used to work with this phage . for practical reasons the ( pr - l - v k )- region of m13vkpcr1 was first inserted into the vector p247 as a hindiii - bamhi fragment . vector p247 is a peg03 derived vector without the two pvuii sites . with the thus - obtained vector pegvkpcr1 dam - negative e . coli cells ( jm110 - strain ) were transformed . subsequently , the hindiii - bamhi - fragment was , after insertion of the v k - region of d9d10 ( pegvkifng ), transferred to the expression vector psvhyghuck . because the v k - region comprises an internal bamhi - site in the fr2 - region , two cloning steps were necessary . first , a 370 bp hindii - bamhi - fragment was cloned into psvhyghuck . subsequently , the remaining 240 bp bamhi - fragment was inserted into the unique bamhi - restriction site of this construct , thus obtaining an expression vector encoding a chimeric light chain with an intron between v and c ( psvhyggfl1 ). fig4 shows schematically the construction of this expression vector . the human γ1 region comprises a unique apai site at the beginning of the c - region . to use this site for linkage with the v h - region , an apai - site had to be created in the beginning of the murine c - region . therefore , the pcr - method was used . vh1back : ( seq id no : 1 ) 5 ′ aggtsmar ctgcag sagtcwgg 3 ′ psti vh1apa : ( seq id no : 5 ) 5 ′ gat gggccc gtcgttttggctgaggag 3 ′ apai wherein : s = c or g m = a or c r = a or g w = a or t with 1 μg total rna from d9d10 hybridoma cells , the first cdna strand was synthesized with random hexanucleotides as primers . amplification with vh1back and vh1apa yielded a 380 bp ( v h - c h ′ )- fragment . this fragment was eluted out of a 2 % lmp agarose gel , digested with psti and apai and cloned into vector peg02 , a puc19 - derived vector in which an apai site was inserted . then the ( v h - c h ′ ) sequence was cloned in vector pegvhpcr2 as a psti - bamhi fragment to yield plasmid p351 . the pegvhpcr2 - vector was obtained by the insertion of the hindiii - bamhi fragment of m13vhpcr1 into the plasmid peg04 , another puc19 - derived vector . the human γ1 sequence available from vector pbgs18 - huigg1 was cloned in vector p351 as an apai fragment . the final construct ( psvgptgfh2 ) with the chimeric heavy chain without intron between the v - and c - regions was finally obtained by inserting the bamhi - hindiii - fragment from peggfh2 into the expression vector psvgptmovhnp . fig5 shows schematically the construction strategy of the expression vector psvgptgfh2 . for the construction of a chimeric light chain without an intron between the variable and the constant kappa region , a unique nari restriction site had to be created in the murine kappa chain gene . this was done by primer - mediated mutagenesis by means of pcr as described by higuchi et al ., nucl . acids res . 16 : 7351 - 7367 ( 1988 ) and ho et al ., gene 77 : 51 - 59 ( 1989 ). the pcr generates mutations by means of the primers . therefore , the pcr has to be performed with two sets of primers . one of the primers of each set contains the desired mutation . both mutated primers are complementary . the amplified dnas show partial overlap because of the complementary primers . after amplification , the new sets of strands are denatured and renatured such that annealing takes place in the position of the complementary primers . then another pcr is performed with only the non - mutated primers to fill in the missing parts of the strands . the first reaction was performed with the primers vk1back and vk1nar , below . the second pcr used the primers ck1nar and ssdnabackw , below . amplification took place by performing a pcr of 32 cycles for 35 seconds at 95 ° c ., one minute at 60 ° c . and 45 seconds at 72 ° c . this yielded two overlapping primary pcr products that could hybridize after denaturation as a heteroduplex . a second amplification with only the two outermost primers ( vk1back and ssdnabackw ) comprised 12 cycles with low annealing temperature ( 1 min . at 95 ° c ., 1 . 3 min . at 45 ° c . and 35 sec . at 72 ° c . ), followed by 20 cycles with higher annealing temperature ( 30 sec . at 55 ° c .). this yielded the total kappa chain sequence with a nari site in the c - region . vk1back : ( seq id no : 6 ) 5 ′ gacatt cagctg acccagtctcca 3 ′ pvuii vk1nar : ( seq id no : 7 ) 5 ′ gatacagtt ggcgcc gcatcagcc 3 ′ nari ck1nar : ( seq id no : 8 ) 5 ′ gctgatgc ggcgcc aactgt 3 ′ nari ssdnabackw : ( seq id no : 9 ) 5 ′ agcggataacaatttcacacagga 3 ′ the human c k - gene in the vector puchucknar already contained a nari - site created by dubois . the human c k - region could then be isolated as a nari - bamhi - fragment . the secondary pcr - fragment was digested with pvuii and nari . the 320 bp ( v k - c k ′ - fragment ) was cloned into vector pegvkpcr1 ( digested with pvuii and bamhi ) together with the nari - bamhi - digested human c k - region . finally , the hindiii - saci - fragment of peggfl2 was transferred to the expression vector psvhyghuck ( digested with hindiii and saci ). this yielded psvhyggfl2 , the chimeric l - chain gene without intron between v and c . fig6 shows schematically the construction of this expression vector . electroporation was performed using the method of potter et al ., proc . natl . acad . sci . usa 81 : 7161 - 7165 ( 1984 ). the cells were first washed in cold pbs , resuspended to 10 6 cells / ml in pbs and kept on ice . 800 μl of this suspension was transferred into the cuvette of the electroporation device ( 0 . 4 cm electrogene pulser ; bio - rad , california ). the dna was added hereto , and after 10 minutes incubation on ice , an electric shock of 200 volts at 960 μfd was applied . after a second incubation of 10 minutes on ice , the cells were centrifuged for 5 minutes at 1000 rpm and resuspended in 24 ml culture medium with 40 μg / ml gentamycin and divided into a 24 well plate ( nunc , roskilde , denmark ). after an incubation of two days at 37 ° c ., the medium was changed with selection medium . for the psvgpt - vectors this was mem with 5 % dialysed fbs , 10 μg / ml thymidin , 250 μg / ml xanthin , 15 μg / ml hypoxanthin , 0 . 1 μg / ml ( first change ) or 0 . 5 μg / ml ( all following changes ) mycophenolic acid and 40 μg / ml gentamycin . for the psvhyg vectors 400 μg / ml hygromycin b and 40μg / ml gentamycin were added to the medium . after 10 days of incubation , the resistant clones could be distinguished . they were transferred to 96 well microtiter plates . as soon as the confluence was greater than 60 %, the supematants were tested in an elisa for antibody production . positive clones were transferred to 80 cm 2 culture flasks . the chimeric light chain construct with an intron - between v and c , psvhyggfl1 , was transfected into 1 . 6 × 10 6 sp2 / o — ag14 cells ( atcc accession number crl - 1581 ; american type culture collection , 12301 parklawn drive , rockville , md . 20852 ) by means of electroporation . after eight days in the presence of selection medium ( 400 μg / ml hygromycin ), thirty wells showed resistant clones of which only 17 remained after three weeks of selection . the transfection efficiency , therefore , amounts to 0 . 9 × 10 − 5 . these 17 clones were transferred to a microtiter plate , and when the confluence amounted to more than 50 %, the supernatant was tested in an elisa for the detection of the human kappa chain . seven clones ( 41 %) had no detectable chimeric light chain product ; five ( 29 %) had a week , three ( 18 %) a good , and two ( 12 %) a very good production of the human kappa chain . the production and secretion of the complete chimeric antibody was showed with western blot . supematants of the human kappa producing 3b3 - and 3d3 transfectomas were separated on a 15 % sds polyacrylamid gel . as a control , the supernatant of sp2 / o - cells was used and some dilutions of human serum . after blotting on a pvdf filter , the kappa chain was immunologically detected with the biotinylated goat - anti - human - kappa antibody . after coloring , it was seen that the light chains , produced by 3b3 and 3d2 , ran as far as those of human serum . with the help of a molecular weight marker , the molecular weight was estimated at 29 to 30 kda which is similar to that of a complete light chain . clone 3d2 showed in the elisa the highest chimeric l - chain production and was therefore chosen for the introduction of a chimeric h - chain gene . during a period of at least six months , no loss of chimeric l - chain production was determined . the chimeric kappa - chain producing transfectoma 3d2 was used for the introduction of the chimeric heavy chain gene without intron between v and c . two separate electroporations were performed wherein 1 × 10 6 3d2 cells were transfected with 6 or 12 μg psvgpt - gfh1 . transfected cells were spread out in a 24 well culture plate in mem - medium . after two days , the cells were fed with ecogpt selection medium with 0 . 15 μg / ml mycophenolic acid . two days later the concentration was increased to 0 . 5 μg / ml . this was also the concentration for all further changes . ten days after infection 72 wells showed resistant clones . the resistant clones were then transferred to a new 24 well culture plate . to allow the clones to grow faster , the cells were refreshed with mem - medium ( without mycophenolic acid ) 14 days after transfection . through this , 40 outgrowing clones could be isolated . this amounts to a final transfection efficiency of 1 × 10 − 5 . when the confluence amounted to more than 50 %, the supernatant was tested in the elisa for the detection of the human γ1 - chain . these cells were also split and cultivated in double wherein one series was cultured in mem - medium , while the other series was cultured in selection medium with 0 . 5 μg / ml mycophenolic acid . for the construction of an expression vector for the fv - fragments of anti - huifn - γ the vector psw1 - vhd1 . 3 - vkd1 . 3 - tag1 was used as described by ward et al . ( 1989 ) nature 341 : 544 - 546 . the v h - domain of the antibody d1 . 3 was eliminated out of the vector by digestion with psti and bsteii and replaced by the v h - fragment of an anti - human - interferon - γ of the hybridoma cell line d9d10 , according to formula ia . the fragment was obtained in sufficient amounts as described in example 5 . the v k - domain of the antibody d1 . 3 was then replaced by a saci - xhoi - fragment according to formula ib comprising the v k - region of anti - huifn - γ . the expression vector thus obtained was named psw1 - fv - anti - huifn - γ . the nucleotide sequences of the v h - and v k - regions , respectively ( formula ia and ib respectively ) ( seq id nos : 10 and 11 , respectively ) of the d9d10 antibody are represented in the accompanying formula form . the parts in bold represent the primers used in the pcr . the underlined parts represent the restriction sites . the strategy of construction is schematically represented in fig7 . plasmid dna was brought into e . coli cells according to the cacl 2 method of mandel et al . (( 1970 ) j . mol biol . 53 : 159 - 162 ) except for the difference that only one heat shock was administered ( instead of five ), namely , 20 sec . at 37 ° c . for a 50 μl reaction , 45 sec . at 37 ° c . for a 100 μl reaction . e . coli dh5α cells ( supe44 , hsdr17 ( r k −, m k +), reca1 , enda1 , gyra96 , thi - 1 , rela1 , del ( argf - laczya ) u169 , ø80d - laczdelm15 ) were spread out after transformation in lb - medium ( 1 % bacto - trypton ); 0 . 5 % yeast extract and 0 . 8 % soft agar ) on a solid lb - plate ( 1 . 5 % agar ) containing 100 μg / ml ampicillin , 0 . 02 % x - gal en 0 . 25 mm iptg . they were incubated overnight at 37 ° c . in this manner clone p330 was obtained . the bacterial clone comprising the expression vector for the production of the fv of the anti - huifn - γ - antibody was grown for 16 hours at 37 ° c . in lb - medium containing 100 μm ampicillin and 1 % glucose . glucose suppresses the lac - promotor which prevents the production of antibody fragments . then the cells were washed twice in 50 mm nacl and resuspended in lb - medium containing 100 μm ampicillin and 0 . 1 - 1 mm iptg for induction of the promoter . this suspension was incubated for 2 to 20 hours in a shaking incubator at 37 ° c . the cells were then isolated by centrifugation ( 7000 rpm , 4 ° c .) and the supernatant tested in an elisa ( see example 8 ) are stored at 4 ° c . the periplasma was isolated as described by skerra et al . ( 1988 ) science 240 : 1038 - 1041 . after induction with iptg , the cells were precipitated by centrifugation , resuspended in tes - buffer ( 0 . 2 m tris - hcl ph 8 . 0 ; 0 . 5 mm edta ; 0 . 5m sucrose ; 10 ml / l culture ) and subjected to an osmotic shock by addition of a 1 / 4 dilution of tes - buffer in water ( 15 ml / l culture ). after 30 minutes on ice the suspension was centrifuged by 8000 rpm for 10 minutes at 4 ° c . the supernatant was centrifuged again at 20 , 000 rpm for 30 minutes to remove the remaining cell debris . the supernatant was directly tested , stored at 4 ° c . or frozen at − 20 ° c . the binding of the fv - fragment to the human ifn - γ molecule was tested in an elisa . the wells of a 96 - well “ maxisorp nunc - immuno plate ” were incubated overnight at 4 ° c . with 2 μg / ml recombinant huifn - γ ( bioferon , laupheim , germany ) in 100 μl of a 50 mm tris - hcl ph 8 . 5 and 10 mm nacl buffer . the stock solution of recombinant huifn - γ was dissolved in 50 mm natrium phosphate and 100 mm ammonium acetate buffer with 12 . 5 mg / ml sucrose , to a concentration of 0 . 7 mg / ml pure protein . the culture plate was decanted and to every well 250 μl blocker ( pbs with 0 . 5 % caseine and 0 . 01 % merthiolate ph 7 . 5 ) was added . after incubation for one hour at 37 ° c . the cells were washed with 0 . 05 % tween - 20 in pbs containing 0 . 01 % merthiolate ( washing buffer ), after which the fv - fragment samples were added ( any dilutions in blocker ). after shaking for 2 hours at 37 ° c ., the material that was not bound was washed away and 100 μl of a 1 μg / ml anti - tag1 antibody in blocker was added to every well . subsequently , the plate was again shaken for two hours and washed three times . after that , a biotinylated sheep anti - mouse - ig - antibody was added ( amersham , buckinghamshire , gb , 100 μl of a 1 / 1000 dilution ). after one hour shaking at 37 ° c . and three times washing , the reaction was finished with the biotinylated peroxidase - streptavidin complex , h 2 o 2 and abts . because no anti - idiotype antibody was available , the detection was performed by means of the tag1 - polypeptide that was linked to the v k - region . the highest expression of fv in the supernatant of 18 hours incubated cell culture amounted to 30 binding units . this means that a 1 / 30 dilution of the fluid was still positive ( green color ) in the elisa for huifn - γ binding . almost no fv was demonstrated in the periplasma for the same induction . this is caused by the fact that the fv - concentration in the periplasma reaches its maximal value after an induction of two hours , after which the fv leaks away into the culture liquid and after 18 hours is found substantially therein . this “ leakage ” out of the cells could be due to a stress situation in the bacteria caused by a high production of a strange protein . in the fluid of cells that were not induced ( absence of iptg ), a basal amount of fv was always present while the fluid of cells with a suppressed promoter , because of the presence of glucose , contained no detectable fv - material . the periplasma preparation method provided already a substantial enrichment of the produced fv because the volume was much small in comparison to that of the supernatant . the periplasmic fraction of one liter culture amounted to 12 ml ( 83 times more concentrated ) and of a 1 to 3 ml culture that amounted to 75 μl ( 13 to 40 times more concentrated ). after a two hour induction with 0 . 1 mm iptg ( the combination giving the highest induction in the periplasma ) the fluid as well as the periplasmic fraction were tested in the elisa . the periplasma had a titer of 200 binding units ; in the supernatant no fv was detected . from these experiments it is clear that e . coli , wherein the fv - gen was introduced produced indeed fv and that the fv was capable of binding huifn - γ . this means that neither the amino acid alterations in the 5 ′- and 3 ′- ends of the v - regions nor the linking of tag1 to v k have an important negative influence on the binding of the fv of d9d10 to the huifn - γ - molecule . to verify whether the fv - fragment produced by e . coli can inhibit or neutralize the activity of huifn - γ , in vitro neutralization tests were performed . for these a549 - cells were used a human carcinoma cell line . this cell line was cultured in mem with 10 % “ newbom calf serum ” ( ncs ) and is sensitive to the antiviral activity of huifn - γ . a human - ifn - γ being just antivirally active ( 167 ng huifn - γ with a specific activity of 2 . 8 × 10 4 u / μg on wish cell ; biogen , gent ) were mixed with serial 1 / 2 logarithmic dilutions of the samples to be tested . these were incubated for 4 hours at 37 ° c . after which the mixtures were disinfected for 6 minutes under uv light . to all the wells 50 , 000 a549 cells were added and the whole was incubated for 20 hours in a co 2 - incubator until the cells had formed a monolayer . the infection was performed with a 1 / 300 dilution of the encephalo myocarditis virus ( emcv ). after 48 hours , when the virus control was totally affected , the living cells were colored with 100 μl of a neutral red solution ( 1 / 30 dilution neutral red in pbs with ca 2 + and mg 2 + ) and stored for 2 to 4 hours in the dark . subsequently , they were washed with pbs ( with ca 2 + and mg 2 + ) and 100 μl acidified alcohol was added to every well . after 20 minutes the plates were read in a multiscan titertek at 542 nm . as controls , the samples in the absence of huifn - γ and ifn - γ in the absence of the sample were used . cell and virus controls were also tested . a 1 / 3 dilution of this fraction appeared to be capable to block the antiviral activity completely . when a combination of the 1 / 3 dilution together with a low ifn - γ dose was brought on the cell , the emc - virus could infect and kill the cells , contrary to the sample with the low ifn - γ concentration alone , with which protection occurred . this inhibiting effect was not due to a possible toxicity of a component from the periplasma because in the absence of virus , the cells were not affected , neither to a stimulation of the virus growth , because the cells were not faster affected in the presence of the periplasmic fraction than in the absence thereof . in a 1 / 6 dilution of the periplasmic fraction , no inhibition of the antiviral activity was observed . the fv - fragment that was purified on an affinity column showed the same neutralizing effects . this indicates that it is no other component from the periplasma that blocks the antiviral activity of huifn - γ . moreover , periplasma of non - induced cells was not capable of neutralizing . this means that the fv of the anti - huifn - γ antibody of d9d10 is also capable of neutralizing the antiviral activity of huifn - γ , despite minor changes in the 5 ′ and 3 ′- ends of the v - regions and the linking of tag1 to v k . the above examples showed that the fv - fragments have a neutralizing effect on the anti - viral activity of interferon - γ . the absence of the constant domains in the fv - fragments and the presence of human - derived constant domains in the chimeric antibodies will reduce the anti - immunoglobulin response when administered to patients .
a method for producing biologically active fv antibody fragments that have a neutralizing effect on the anti - viral activity of human interferon - gamma by inserting an isolated nucleic acid , having nucleotide sequences that encode the v h and v l domains of the d9d10 monoclonal antibody and a nucleotide sequence that encodes a linker peptide which links the v h and v l domains , into a suitable expression vector , in order to encode f v antibody fragments . such fv antibody fragments can be used to treat human diseases , such as endotoxic shock , local inflammation , cerebral malaria , and autoimmune arthritis .